Neal H Shorstein1, Liyan Liu2, James A Carolan2, Lisa Herrinton2. 1. From the Departments of Ophthalmology and Quality, Kaiser Permanente, Walnut Creek, California, USA (N.H.S.), Division of Research, Kaiser Permanente Northern California, Oakland, California (L.L, L.H.), Department of Ophthalmology, Kaiser Permanente San Rafael, California (J.A.C.). Electronic address: neal.shorstein@gmail.com. 2. From the Departments of Ophthalmology and Quality, Kaiser Permanente, Walnut Creek, California, USA (N.H.S.), Division of Research, Kaiser Permanente Northern California, Oakland, California (L.L, L.H.), Department of Ophthalmology, Kaiser Permanente San Rafael, California (J.A.C.).
Abstract
PURPOSE: To estimate the association of cefuroxime and moxifloxacin in relation to the occurrence of endophthalmitis following phacoemulsification cataract surgery. DESIGN: Retrospective clinical cohort study. METHODS: We studied patients with noncomplex phacoemulsification cataract surgery in Kaiser Permanente Northern California during 2014-2019. Data were obtained for acute, postoperative endophthalmitis within 90 days of phacoemulsification, including culture and antibiogram results, intracameral and topical antibiotic agent, and dose. In a post hoc analysis, we also examined preoperative anterior chamber depth (ACD) and postoperative anterior chamber volume (ACV). RESULTS: Of 216,141 surgeries, endophthalmitis occurred in 0.020% of moxifloxacin-injected eyes and 0.013% of cefuroxime eyes (relative risk 1.62 with 95% CI 0.82-3.20, P = .16). Of the 34 (0.016%) cases of endophthalmitis, cefuroxime 1 mg was injected into 13 eyes and moxifloxacin 0.1% into 21 eyes. Organisms with antibiograms were identified in 12 (35%) cases. Of these, bacteria recovered from cefuroxime-injected eyes were resistant to cefuroxime in all cases (4/4), with Enterococcus comprising half of these. In eyes injected with moxifloxacin 0.1%, 6 out of 7 organisms were sensitive to moxifloxacin injected with 0.1 mL and in 1 eye injected with 1 mL. Streptococcus was the most common organism recovered (6/9) in moxifloxacin-injected eyes. Preoperative ACD and postoperative calculated ACV were higher in eyes injected with moxifloxacin. CONCLUSIONS: Endophthalmitis cases with positive cultures were generally related to organism resistance in cefuroxime eyes but to sensitive organisms in moxifloxacin eyes. Moxifloxacin doses may have been insufficient in eyes with larger ACV.
PURPOSE: To estimate the association of cefuroxime and moxifloxacin in relation to the occurrence of endophthalmitis following phacoemulsification cataract surgery. DESIGN: Retrospective clinical cohort study. METHODS: We studied patients with noncomplex phacoemulsification cataract surgery in Kaiser Permanente Northern California during 2014-2019. Data were obtained for acute, postoperative endophthalmitis within 90 days of phacoemulsification, including culture and antibiogram results, intracameral and topical antibiotic agent, and dose. In a post hoc analysis, we also examined preoperative anterior chamber depth (ACD) and postoperative anterior chamber volume (ACV). RESULTS: Of 216,141 surgeries, endophthalmitis occurred in 0.020% of moxifloxacin-injected eyes and 0.013% of cefuroxime eyes (relative risk 1.62 with 95% CI 0.82-3.20, P = .16). Of the 34 (0.016%) cases of endophthalmitis, cefuroxime 1 mg was injected into 13 eyes and moxifloxacin 0.1% into 21 eyes. Organisms with antibiograms were identified in 12 (35%) cases. Of these, bacteria recovered from cefuroxime-injected eyes were resistant to cefuroxime in all cases (4/4), with Enterococcus comprising half of these. In eyes injected with moxifloxacin 0.1%, 6 out of 7 organisms were sensitive to moxifloxacin injected with 0.1 mL and in 1 eye injected with 1 mL. Streptococcus was the most common organism recovered (6/9) in moxifloxacin-injected eyes. Preoperative ACD and postoperative calculated ACV were higher in eyes injected with moxifloxacin. CONCLUSIONS: Endophthalmitis cases with positive cultures were generally related to organism resistance in cefuroxime eyes but to sensitive organisms in moxifloxacin eyes. Moxifloxacin doses may have been insufficient in eyes with larger ACV.
Authors: David F Chang; N Venkatesh Prajna; Loretta B Szczotka-Flynn; Beth Ann Benetz; Jonathan H Lass; Robert C OʼBrien; Harry J Menegay; Susanne Gardner; Madhu Shekar; Sharmila Rajendrababu; Douglas J Rhee Journal: J Cataract Refract Surg Date: 2020-03 Impact factor: 3.351
Authors: Mathias V Melega; Monica Alves; Rodrigo Pessoa Cavalcanti Lira; Iuri Cardoso da Silva; Bruna Gil Ferreira; Hermano Lg Assis Filho; Fernando Rodrigo Pedreira Chaves; Alexandre A F Martini; Livia Maria Dias Freire; Roberto Dos Reis; Carlos Eduardo Leite Arieta Journal: J Cataract Refract Surg Date: 2019-01-25 Impact factor: 3.351
Authors: Francisco Bandeira E Silva; Linda Christian Carrijo-Carvalho; Anderson Teixeira; Denise de Freitas; Fabio Ramos de Souza Carvalho Journal: Cornea Date: 2016-12 Impact factor: 2.651
Authors: Lisa J Herrinton; Neal H Shorstein; John F Paschal; Liyan Liu; Richard Contreras; Kevin L Winthrop; William J Chang; Ronald B Melles; Donald S Fong Journal: Ophthalmology Date: 2015-10-14 Impact factor: 12.079